Clinical Trial Update: Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating posaconazole to prevent influenza-associated invasive pulmonary aspergillosis in critically ill patients has completed and results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pulmonary Aspergillosis

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Aspergillosis; Pulmonary, Invasive (Etiology) | Phase 4 | Status: COMPLETED | Results posted: 2025-04-08